Warning: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

UK Mid Cap strategy - June 2021

  • 15 July 2021 (5 min read)

The attractions of the UK as a place to invest visible through the on-going flow of M&A activity

  • June was again a volatile month as the market continues to react to data
  •  FTSE All-Share Index finished the month up
  • Growth stocks, in general, continued their recent recovery

What’s happening?

In June, the market was initially buoyed by data showing further economic recovery and improved sentiment regarding the pandemic as the UK reported no daily deaths from COVID-19 on the first day of the month, for the first time since the pandemic began. This early optimism, however, turned to caution as rising global inflation data led the market to worry that central bank stimulus would be tapered sooner than previously expected and this was in part confirmed when the US Federal Reserve’s (Fed’s) median interest rate projection changed from one of no increases before 2024 to potentially two rises in 2023.

In addition to this, both domestically and globally, the case numbers of the Delta variant rose steeply in the latter half of June causing a delay to the final unlocking of UK restrictions. Commodity prices also came under pressure during June following a period of very strong growth as a result of the Fed’s actions and helped by China releasing stockpiles and clamping down on speculation. The oil price, however, was an exception to this as Brent crude and West Texas Intermediate surged through $70 per barrel, to the highest levels since October 2018. The increase reflected growing demand for fuel from the recovering global economy and potential delays to a deal between the US and Iran over the latter’s nuclear power development. The FTSE All-Share Index finished the month up 0.16%1  , with the oil price strength helping the FTSE 100 Index gain 0.41%1  . It was also a good month of returns for small-cap indices, with a gain of 1.23%1  , but the more domestically-focused FTSE 250 Index fell -1.18%1  , impacted by the Delta variant worries. On a year-to-date basis, the strategy benchmark, FTSE 250 ex-investment trusts Index, has risen 11.97%1

Portfolio positioning and performance

The strategy outperformed its index in June as it benefited from strong monthly performances from Future, Darktrace, and Learning Technologies Group. Detractors from performance included Just Group as yields pulled back during the period, as well as Clinigen following a profit warning that Proluekin sales would be below expectations, and Morrisons after the supermarket received a takeover approach but is not held within the strategy. Sector allocations had a slightly negative impact overall with technology contributing positively and consumer staples contributing negatively.

We used share price volatility to add to core holdings and make reductions. New holdings were taken in Made.com Group as part of the initial public offering process. Holdings in Rank and St Modwen Properties, which received a takeover approach from Blackstone, were sold. Additions of note included supporting fund raisings for both Rathbones (to buy Saunderson House) and Draper Esprit (to accelerate its business model). The strategy’s investment philosophy and process remained unaltered.


June was again a volatile month as the market continued to react to every inflation, employment, and GDP2  print. This is driving the performance of both markets and sectors as investors try and anticipate the next central bank move.

Growth stocks in general continued their recent recovery as investors were nervous that central banks would dampen the recovery, removing some of the exuberance from cyclical stocks. In addition to this, the rapid spread of the highly transmissible Delta variant of COVID-19 is another cause for concern. However, economic data over the last three months has generally been very strong and global forecasting bodies are now projecting that the UK will be one of the fastest growing of the major developed economies in both 2021 and 2022. The attractions of the UK as a place to invest are manifesting themselves most visibly through the ongoing flow of M&A activity in the UK-listed space. With so much liquidity still in the system, this is likely to continue to feature over the coming months.

No assurance can be given that the UK Mid Cap Strategy will be successful. Investors can lose some or all of their capital invested. The UK Mid Cap strategy is subject to risks including; Equity; Smaller companies risk; Liquidity risk.

  • Qmxvb21iZXJnLCBhcyBhdCAzMC8wNi8yMDIx
  • Qmxvb21iZXJnLCBhcyBhdCAzMC8wNi8yMDIx
  • Qmxvb21iZXJnLCBhcyBhdCAzMC8wNi8yMDIx
  • Qmxvb21iZXJnLCBhcyBhdCAzMC8wNi8yMDIx
  • Qmxvb21iZXJnLCBhcyBhdCAzMC8wNi8yMDIx
  • R0RQOiBHcm9zcyBEb21lc3RpYyBQcm9kdWN0
Read the full article
Download article (225.01 KB)

Visit the Fund centre

AXA Framlington UK Mid Cap strategy

The aim of this Fund is to provide long-term capital growth

View funds


Invest in a variety of industries, regions and countries, or invest according to a theme or sector.rs globally.


    Not for Retail distribution:

    This document is intended exclusively for Professional, Institutional, Qualified or Wholesale Clients / Investors only, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.

    Past performance is not a guide to current or future performance, and any performance or return data displayed does not take into account commissions and costs incurred when issuing or redeeming units. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Exchange-rate fluctuations may also affect the value of their investment. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding.

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities. The strategies discussed in this document may not be available in your jurisdiction.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. 

    Are you an IFA or other Professional Investor ?

    Are you a financial advisor, institutional, or other professional investor?

    This section is for professional investors only. You need to confirm that you have the required investment knowledge and experience to view this content. This includes understanding the risks associated with investment products, and any other required qualifications according to the rules of your jurisdiction.